Mitoxantrone hydrochloride infusion for the prevention of bladder cancer recurrence after surgery
- VernacularTitle:盐酸米托蒽醌灌注预防膀胱癌术后复发
- Author:
Limin ZHANG
;
Tongliang CHEN
- Publication Type:Journal Article
- Keywords:
膀胱癌, 米托蒽醌, 膀胱灌注
- From:
Chinese Journal of Rehabilitation Theory and Practice
2004;10(8):463-463
- CountryChina
- Language:Chinese
-
Abstract:
目的探讨盐酸米托蒽醌(MTZ)膀胱内灌注预防膀胱癌术后复发的临床疗效。方法对63例浅表性膀胱癌患者行经尿道膀胱肿瘤切除术或膀胱部份切除术,术后用米托蒽醌12mg进行膀胱灌注,随访6—30月。 结果63例患者均未见全身性药物不良反应,复发6例(9.2%)。结论米托蒽醌膀胱灌注预防膀胱癌术后复发疗效满意,安全性好。